These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 27811359

  • 1. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
    Li W, Li J, Wang Y, Zhang K, Li N, Tian Z, Ni B, Wang H, Ruan Z.
    Oncotarget; 2016 Dec 06; 7(49):80586-80598. PubMed ID: 27811359
    [Abstract] [Full Text] [Related]

  • 2. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma.
    Liu T, Sun Q, Li Q, Yang H, Zhang Y, Wang R, Lin X, Xiao D, Yuan Y, Chen L, Wang W.
    Mol Cancer Ther; 2015 Feb 06; 14(2):429-39. PubMed ID: 25504751
    [Abstract] [Full Text] [Related]

  • 3. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
    Xie P, Yang JP, Cao Y, Peng LX, Zheng LS, Sun R, Meng DF, Wang MY, Mei Y, Qiang YY, Cao L, Xiang YQ, Luo DH, Yun JP, Huang BJ, Jia LJ, Qian CN.
    Cell Death Dis; 2017 Jun 01; 8(6):e2834. PubMed ID: 28569775
    [Abstract] [Full Text] [Related]

  • 4. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y, Zhang J, Tian Y, Xue C, Hu Z, Zhang L.
    Drug Des Devel Ther; 2015 Jun 01; 9():4897-907. PubMed ID: 26345996
    [Abstract] [Full Text] [Related]

  • 5. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
    Li N, Feng L, Han HQ, Yuan J, Qi XK, Lian YF, Kuang BH, Zhang YC, Deng CC, Zhang HJ, Yao YY, Xu M, He GP, Zhao BC, Gao L, Feng QS, Chen LZ, Yang L, Yang D, Zeng YX.
    Cancer Lett; 2016 Oct 10; 381(1):14-22. PubMed ID: 27424523
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
    Zhang M, Zhou X, Zhou K.
    Int J Mol Med; 2013 Mar 10; 31(3):621-7. PubMed ID: 23314035
    [Abstract] [Full Text] [Related]

  • 7. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B, Gu Q, Li J.
    Oncol Rep; 2017 Jul 10; 38(1):317-324. PubMed ID: 28586035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High expression of sphingosine kinase 1 is associated with poor prognosis in nasopharyngeal carcinoma.
    Li W, Tian Z, Qin H, Li N, Zhou X, Li J, Ni B, Ruan Z.
    Biochem Biophys Res Commun; 2015 May 01; 460(2):341-7. PubMed ID: 25778867
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissié J, Malavaud B, Waxman J, Cuvillier O.
    Cancer Res; 2010 Nov 01; 70(21):8651-61. PubMed ID: 20959468
    [Abstract] [Full Text] [Related]

  • 12. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W, Yi M, Chen S, Li J, Zhang H, Xiong W, Li G, Li X, Xiang B.
    J Cell Physiol; 2017 Oct 01; 232(10):2829-2840. PubMed ID: 27891591
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
    Li Q, Ni W, Deng Z, Liu M, She L, Xie Q.
    Fundam Clin Pharmacol; 2017 Jun 01; 31(3):301-310. PubMed ID: 28078787
    [Abstract] [Full Text] [Related]

  • 15. Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase.
    Motyl J, Przykaza Ł, Boguszewski PM, Kosson P, Strosznajder JB.
    Neuropharmacology; 2018 Jun 01; 135():139-150. PubMed ID: 29481916
    [Abstract] [Full Text] [Related]

  • 16. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
    Xu L, Zhang Y, Gao M, Wang G, Fu Y.
    Biochem Biophys Res Commun; 2016 Apr 15; 472(4):662-8. PubMed ID: 26920060
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
    Wang X, Sun Y, Peng X, Naqvi SMAS, Yang Y, Zhang J, Chen M, Chen Y, Chen H, Yan H, Wei G, Hong P, Lu Y.
    Cancer Control; 2020 Apr 15; 27(1):1073274820976664. PubMed ID: 33317322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.